BiotechTube
Home/Altimmune/Scott Harris, M.D.
SH

Scott Harris, M.D.

Chief Medical Officer

Altimmune

Therapeutic Areas

ObesityMetabolic Dysfunction-Associated Steatohepatitis (MASH)Hypercholesterolemia

Altimmune Pipeline

DrugIndicationPhase
PemvidutideObesityPhase 2
ALT-400Undisclosed Metabolic IndicationPreclinical

Leadership Team at Altimmune

VK
Vipin K. Garg, Ph.D.
President and Chief Executive Officer
RE
Richard Eisenstadt
Chief Financial Officer
CM
Cynthia Musante, Ph.D.
Senior Vice President, Research & Development
WS
William Symonds, Pharm.D.
Board Member
JG
John Gill
Board Member
View full Altimmune profile